Meeting
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
Authors
Muhammad Danyal Ahsan
Weill Cornell Medicine - Qatar, Doha, Qatar
Muhammad Danyal Ahsan , Emily M. Webster , Ryan M Kahn , Sarah R. Levi , Murtaza Qazi , Luiza Perez , Jesse T. Brewer , Laura Keenahan , Evelyn Cantillo , Eloise Chapman-Davis , Kevin Holcomb , Melissa Kristen Frey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Cervical Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5543)
DOI
10.1200/JCO.2023.41.16_suppl.5543
Abstract #
5543
Poster Bd #
238
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC).
First Author: Anup Kasi
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery